OBiO Biotechnology (Shanghai) Corp. Ltd., (“OBiO” or “the Company”), announced it will be attending the American Society of Gene & Cell Therapy (ASGCT) 24th Annual Meeting to be held virtually from May 11-14, 2021.
Feel free to join the OBiO virtual booth livestream on May 11 and 13 from 10:30 a.m. to 12:00 p.m. EST, to learn more about gene and cell therapy market access in China and OBiO’s role as a CDMO to help biotech speed up their commercialization worldwide. Dr. Guodong Jia, General Manager of OBiO, will exchange and share insights on gene therapy product research and manufacturing with other global industry professionals around the world.
For OBiO’s pre-show listing, please visit: https://s36.a2zinc.net/clients/asgct/asgct2021/Public/eBooth.aspx?IndexInList=63&FromPage=Exhibitors.aspx&ParentBoothID=&ListByBooth=true&BoothID=100419
